Skip to content

Flyout Menu

About Us
- Overview
- The Sai Way
- Leadership
- Quality
- Facilities
  - Boston
  - Manchester
  - Hyderabad
  - Bidar
Our Capabilities
Responsibility
Knowledge Hub
Investors
Careers
Contact us

About Us
Overview

The Sai Way

Leadership

Quality

Facilities

– Boston

– Manchester

– Hyderabad

– Bidar
Our Capabilities
Discovery

Integrated Drug Discovery (IDD)

CADD & Structural Biology

Synthetic & Medicinal Chemistry

In Vitro Biology

DMPK (Drug Metabolism & Pharmacokinetics)

In Vivo Pharmacology

Safety & Toxicology

Compound Management
Drug Substance Development

Discovery Process Chemistry

Process Development

Analytical Development

Process Engineering

Particle Science & Engineering

Developability & Pre-Formulation
Drug Substance Manufacturing

Product Types

Infrastructure

Engineering Technologies

Formulations

New Chemical Entity (NCE) formulation development

Clinical Formulation Supplies
New Modalities

Antibody–Drug Conjugates

Peptides

Oligos
Responsibility
Sustainability

Health, Safety and Environment

Corporate Social Responsibility
Knowledge Hub
Newsroom

Blogs

Case Studies
Investors
Investor Relations

Financial Information

Annual reports

Corporate Governance

Shareholder Services

Disclosures
Careers
Contact us

About Us
Overview

The Sai Way

Leadership

Quality

Facilities

– Boston

– Manchester

– Hyderabad

– Bidar
Our Capabilities
Discovery

Integrated Drug Discovery (IDD)

CADD & Structural Biology

Synthetic & Medicinal Chemistry

In Vitro Biology

DMPK (Drug Metabolism & Pharmacokinetics)

In Vivo Pharmacology

Safety & Toxicology

Compound Management
Drug Substance Development

Discovery Process Chemistry

Process Development

Analytical Development

Process Engineering

Particle Science & Engineering

Developability & Pre-Formulation
Drug Substance Manufacturing

Product Types

Infrastructure

Engineering Technologies

Formulations

New Chemical Entity (NCE) formulation development

Clinical Formulation Supplies
New Modalities

Antibody–Drug Conjugates

Peptides

Oligos
Responsibility
Sustainability

Health, Safety and Environment

Corporate Social Responsibility
Knowledge Hub
Newsroom

Blogs

Case Studies
Investors
Investor Relations

Financial Information

Annual reports

Corporate Governance

Shareholder Services

Disclosures
Careers
Contact us

About Us
Main Menu

Overview

The Sai Way

Leadership

Quality

Facilities

Boston

Manchester

Hyderabad

Bidar
Our Capabilities
Main Menu

Discovery

Integrated Drug Discovery (IDD)

CADD & Structural Biology

Synthetic & Medicinal Chemistry

In Vitro Biology

DMPK (Drug Metabolism & Pharmacokinetics)

In Vivo Pharmacology

Safety & Toxicology

Compound Management

Drug Substance Development

Discovery Process Chemistry

Process Development

Analytical Development

Process Engineering

Particle Science & Engineering

Developability & Pre-Formulation

Drug Substance Manufacturing

Product Types

Infrastructure

Engineering Technologies

Formulations

New Chemical Entity (NCE) formulation development

Clinical Formulation Supplies

New Modalities

Antibody–Drug Conjugates

Peptides

Oligos
Sustainability
Sustainability

Health, Safety and Environment

Corporate Social Responsibility
Knowledge Hub
Newsroom

Blogs

Case Studies
Investors
Investor Relations

Financial Information

Annual reports

Corporate Governance

Shareholder Services

Disclosures
Careers
Contact us

About Us
Main Menu

Overview

The Sai Way

Leadership

Quality

Facilities

Boston

Manchester

Hyderabad

Bidar
Our Capabilities
Main Menu

Discovery

Integrated Drug Discovery (IDD)

CADD & Structural Biology

Synthetic & Medicinal Chemistry

In Vitro Biology

DMPK (Drug Metabolism & Pharmacokinetics)

In Vivo Pharmacology

Safety & Toxicology

Compound Management

Drug Substance Development

Discovery Process Chemistry

Process Development

Analytical Development

Process Engineering

Particle Science & Engineering

Developability & Pre-Formulation

Drug Substance Manufacturing

Product Types

Infrastructure

Engineering Technologies

Formulations

New Chemical Entity (NCE) formulation development

Clinical Formulation Supplies

New Modalities

Antibody–Drug Conjugates

Peptides

Oligos
Sustainability
Sustainability

Health, Safety and Environment

Corporate Social Responsibility
Knowledge Hub
Newsroom

Blogs

Case Studies
Investors
Investor Relations

Financial Information

Annual reports

Corporate Governance

Shareholder Services

Disclosures
Careers
Contact us

Lvl 2

Capabilities - Level 2, Drug Substance Development

Process Engineering

Wayne Smith / October 22, 2025

Capabilities - Level 2, Drug Substance Development

Analytical Development

Wayne Smith / October 22, 2025

Capabilities - Level 2, Drug Substance Development

Process Development

Wayne Smith / October 22, 2025

Capabilities - Level 2, Drug Substance Development

Discovery Process Chemistry

Wayne Smith / October 22, 2025

Capabilities - Level 2, Discovery

Compound Management

Wayne Smith / October 22, 2025

Capabilities - Level 2, Discovery

Safety & Toxicology

Wayne Smith / October 22, 2025

Capabilities - Level 2, Discovery

DMPK (Drug Metabolism & Pharmacokinetics)

Wayne Smith / October 22, 2025

Capabilities - Level 2, Discovery

In Vitro Biology

Wayne Smith / October 22, 2025

Capabilities - Level 2, Discovery

Synthetic & Medicinal Chemistry

Wayne Smith / October 22, 2025

Capabilities - Level 2, Discovery

CADD & Structural Biology

Wayne Smith / October 22, 2025

← Previous 1 2 3 Next →

DS-7, IKP Knowledge Park,
Turkapally Village, Shameerpet Mandal,
Medchal-Malkajgiri District-500078,
Telangana, India

Company

Main Menu

About Us
Investors
Careers
Contact us

Our Capabilities

Main Menu

Discovery
Drug Substance Development
Drug Substance Manufacturing
Formulations
New Modalities

Knowledge Hub

Main Menu

News
Blogs
Case Studies

Legal

Main Menu

Privacy Policy
Cookie Policy
Terms & Conditions

© 2026 Sai Life Sciences All rights reserved.

Facebook-f Instagram Linkedin-in X-twitter Youtube